Hologic Q1 2023 Earnings Report
Key Takeaways
Hologic reported a decrease in revenue by 27.0% to $1,074.2 million, but exceeded revenue expectations. Diagnostics and Surgical businesses experienced double-digit organic revenue growth ex. COVID-19. The company increased its full-year fiscal 2023 guidance for both revenue and EPS.
Each base franchise exceeded revenue expectations and delivered robust profitability.
Diagnostics and Surgical businesses achieved double-digit organic revenue growth ex. COVID-19.
Breast Health business showed encouraging signs of recovery.
Full-year fiscal 2023 guidance for revenue and EPS was increased.
Hologic
Hologic
Hologic Revenue by Segment
Hologic Revenue by Geographic Location
Forward Guidance
Hologic expects low double-digit constant currency organic revenue growth ex. COVID-19 in each division for the second quarter and full year 2023.
Positive Outlook
- Expects low double-digit constant currency organic revenue growth ex. COVID-19 in each division for the full-year fiscal 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income